TOKYO -- Orix will purchase all outstanding shares in veterinary medicine maker Fujita Pharmaceutical this month as the company quickly prepares for what it sees as a possible big expansion of the business domestically if Japan ratifies the Trans-Pacific Partnership.
Livestock operations in Japan are expected to increase in scale if the wide-ranging trade and economic pact takes effect, raising the risk of infectious diseases among animals.
